Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
27 Jul 2022 On business and financial situation The Company releases the press release related to the first half 2022 financial results   Download
27 Jul 2022 On business and financial situation The Company releases the first half 2022 financial results presentation Download
04 Jul 2022 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2022 Download
30 Jun 2022 Other relevant information The Company informs about the dividends payment Download
16 Jun 2022 Other relevant information The Company has agreed to execute the capital reduction approved by the 2022 Ordinary General Meeting to amortize the shares acquired in the framework of the own shares repurchase programs   Download

Pages

Date Title Description PDF
04 Oct 2018 Share capital increases and reductions Private placement capital increase addressed to institutional investors, excluding  preferential subscription rights Download
02 Oct 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the third quarter of 2018 Download
24 Sep 2018 Others on business performance and financial information Updated information on business, financial position and risk factors Download
24 Sep 2018 Share capital increases and reductions Intention to raise gross proceeds by means of an offer addressed to institutional investors, excluding preferential subscription rights Download
26 Jul 2018 Información sobre resultados ROVI releases the 2018 first half results presentation Download

Pages